Andrew Hykes, Chief Operating Officer at Inari Medical, Inc. (NARI), sold 7,691 shares at $72.70 ($568K) on 2022-02-01, disclosed to the SEC on 2022-02-03.
Open-market sale of $568k NARI by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.70 | 1,900 | $138K | 24.3% |
| 2 | $73.63 | 1,381 | $102K | 17.9% |
| 3 | $73.63 | 1,381 | $102K | 17.9% |
| 4 | $74.59 | 1,310 | $98K | 17.2% |
| 5 | $74.59 | 1,310 | $98K | 17.2% |
| 6 | $75.41 | 409 |
| $31K |
| 5.4% |
| Total | $73.82 avg | 7,691 | $568K | 100% |
| Filing → |
| NARI | SELL | 2024-10-31 | $150K | — | Filing → |
| NARI | SELL | 2024-08-22 | $150K | — | Filing → |
| NARI | SELL | 2024-07-24 | $166K | — | Filing → |